OpenLobby.EU
Explore

CureVac SE

CureVac is a pioneer in the field of development and production of a completely new class of therapies based on the messenger molecule mRNA.

Lobbying Activity

Meeting with Cristian-Silviu Buşoi (Member of the European Parliament)

28 Jun 2023 · ongoing work in oncology and innovation

Meeting with Maurits-Jan Prinz (Cabinet of Commissioner Thierry Breton)

30 Nov 2022 · Medicines manufacturing and pandemic preparedness

Meeting with Karsten Lucke (Member of the European Parliament)

21 Nov 2022 · Corona Impfstoffe

Meeting with Kathleen Van Brempt (Member of the European Parliament, Committee chair)

8 Sept 2022 · Lessons learned from the COVID-19 pandemic and the work of the COVI Committee

Response to Ex-post evaluation of Horizon 2020

29 Jul 2022

CureVac appreciates the chance to provide overall feedback to the Horizon 2020 programme and would like to take this opportunity to thank the European Commission for successfully stimulating research and innovation in the European Union. The Horizon 2014-2020 programmes have contributed to CureVac´s efforts in expanding expertise through R&D and further developing its messenger RNA (mRNA) platform. The European Commission has encouraged and contributed to the research and innovation of a foundational RNA-technology-platform in Europe for the benefit of global health which now has proven its potential to provide for new classes of medicines and treatments.
Read full response

Meeting with Thierry Breton (Commissioner)

2 Mar 2021 · Vaccine production

Meeting with Sandra Gallina (Director-General Health and Food Safety)

8 Feb 2021 · meeting with Curevac - vaccines

Meeting with Ursula von der Leyen (President) and SANOFI and

31 Jan 2021 · Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements

Meeting with Mariya Gabriel (Commissioner)

6 Jul 2020 · CureVac Signature

Meeting with Ursula von der Leyen (President)

16 Mar 2020 · Videconderence with CureVac representatives on COVID-19

Meeting with Mariya Gabriel (Commissioner)

16 Mar 2020 · COVID-19